The new role of dopamine agonists in the management of Parkinson's disease and restless legs syndromeKOLLER, William C.Neurology. 2002, Vol 58, Num 4, issn 0028-3878, 94 p., SUP1Serial Issue

Long-term studies of dopamine agonistsHUBBLE, Jean P.Neurology. 2002, Vol 58, Num 4, pp S42-S50, issn 0028-3878, SUP1Article

Tremor and dopamine agonistsELBLE, Rodger J.Neurology. 2002, Vol 58, Num 4, pp S57-S62, issn 0028-3878, SUP1Article

Neuroprotection and dopamine agonistsSCHAPIRA, Anthony H. V.Neurology. 2002, Vol 58, Num 4, pp S9-S18, issn 0028-3878, SUP1Article

Relevance of motor complications in Parkinson's diseaseADLER, Charles H.Neurology. 2002, Vol 58, Num 4, pp S51-S56, issn 0028-3878, SUP1Article

Dopamine agonists and sleep in Parkinson's diseaseCANTOR, Charles R; STERN, Matthew B.Neurology. 2002, Vol 58, Num 4, pp S71-S78, issn 0028-3878, SUP1Article

Pharmacology of dopamine agonists in the treatment of Parkinson's diseaseJENNER, Peter.Neurology. 2002, Vol 58, Num 4, pp S1-S8, issn 0028-3878, SUP1Article

The role of dopamine agonists in the treatment of early Parkinson's diseaseOLANOW, C. Warren.Neurology. 2002, Vol 58, Num 4, pp S33-S41, issn 0028-3878, SUP1Article

Depression associated with Parkinson's disease: Clinical features and treatmentOKUN, Michael S; WATTS, Ray L.Neurology. 2002, Vol 58, Num 4, pp S63-S70, issn 0028-3878, SUP1Article

Restless legs syndrome: Treatment with dopaminergic agentsCOMELLA, Cynthia L.Neurology. 2002, Vol 58, Num 4, pp S87-S92, issn 0028-3878, SUP1Article